Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Perspective Therapeutics (CATX) Loans - Net (2022)

Perspective Therapeutics' Loans - Net history spans 1 years, with the latest figure at $6.1 million for Q4 2022.

On a quarterly basis, Loans - Net changed N/A to $6.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $6.1 million, a N/A change, with the full-year FY2022 number at $6.1 million, changed N/A from a year prior.
Loans - Net hit $6.1 million in Q4 2022 for Perspective Therapeutics.
Over the last five years, Loans - Net for CATX hit a ceiling of $6.1 million in Q4 2022 and a floor of $6.1 million in Q4 2022.